Form 8-K - Current report:
SEC Accession No. 0001561743-19-000013
Filing Date
2019-01-17
Accepted
2019-01-17 16:21:23
Documents
2
Period of Report
2019-01-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjanuary172019.htm 8-K 34165
2 EXHIBIT 99.1 pressrelease.htm EX-99.1 10795
  Complete submission text file 0001561743-19-000013.txt   46112
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 19531184
SIC: 2834 Pharmaceutical Preparations